Cargando…
Advanced glycation end products in isoproterenol-induced acute myocardial infarction
BACKGROUND: Isoproterenol is a synthetic catecholamine that can produce diffuse myocardial necrosis at high doses. Advanced glycation end products (AGEs) are involved in the development and progression of cardiovascular disease, including acute coronary syndrome. The purpose of the study was to dete...
Autores principales: | Timercan, Tatiana, Şveţ, Inna, Pantea, Valeriana, Ambros, Ala, Lîsîi, Leonid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709963/ https://www.ncbi.nlm.nih.gov/pubmed/31460503 http://dx.doi.org/10.15386/mpr-1348 |
Ejemplares similares
-
CUPRAC-Reactive Advanced Glycation End Products as Prognostic Markers of Human Acute Myocardial Infarction
por: Bayarsaikhan, Govigerel, et al.
Publicado: (2021) -
Characterization of advanced glycation end products and their receptor (RAGE) in an animal model of myocardial infarction
por: Fracasso, Bianca de Moraes, et al.
Publicado: (2019) -
The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023) -
Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction
por: Boarescu, Paul-Mihai, et al.
Publicado: (2019) -
Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)